Skip to main content

Table 1 Association of Ku80 expression with clinical characteristics of 106 patients with lung adenocarcinoma

From: Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

Characteristics patients (n = 106) Ku80 mRNA level   P Ku80 protein level   P
Low (n = 28) High (n = 78) Low ( n = 23) High (n  = 83)
Age at diagnosis of lung AC     0.202    
mean ± SD 58.33 ± 10.50 57.45 ± 9.96 60.79 ± 11.71     
Gender     0.371    0.151
Male 43(40.6) 9(32.1) 34(43.6)   6(26.1) 37(40.6)  
Female 63(59.4) 19(67.9) 44(56.4)   17(73.9) 46(55.4)  
Smoking status     0.238    0.13
Never 32(30.2) 11(39.3) 21(26.9)   10(43.5) 22(26.5)  
Former and current smokers 74(69.8) 17(60.7) 57(73.1)   13(56.5) 61(73.5)  
Tumor grade     0.062    0.114
Well differentiated 36(34.0) 15(53.6) 21(34.0)   12(52.2) 24(28.9)  
Moderately differentiated 32(30.2) 7(25.0) 32(30.2)   5(21.7) 27(32.5)  
Poorly differentiated 38(35.8) 6(21.4) 32(35.8)   6(26.1) 32(38.6)  
Lymph node metastasis    0.001    0.001
Positive 73(68.9) 11(39.3) 62(79.5)   6(26.1) 67(80.7)  
Negative 33(31.1) 17(60.7) 16(20.5)   17(73.9) 16(19.3)  
Disease stage     0.014    0.017
I 23(21.7) 10(35.7) 13(16.7)   10(43.5) 13(21.7)  
II 57(53.8) 13(46.4) 44(56.4)   9(39.1) 48(53.8)  
III 26(24.5) 5(17.9) 21(26.9)   4(17.4) 22(26.5)